by 
US International Trade Commission (ITC) issued an order which he could prevent Apple from importing its Apple Watches against a medical technology company for patent infringement fields.
The commission upheld a judge's ruling from January that found Apple infringed on Massimo's patent rights related to light-based technology used to measure oxygen levels in the blood. However, the decision will not have an immediate effect, as it must be reviewed by the President and is possible. addresses.
Masimo CEO Joe Qian said the decision “sends a strong message that even the world's largest company is not above the law”.
The Biden administration has 60 days to decide whether to veto the import ban based on policy concerns before it takes effect, although presidents have rarely vetoed bans in the past.
Apple also has the option to appeal the ban in the US Court of Appeals for the Federal Circuit after the review period ends.
“Masimo wrongly tried to use the ITC to keep a potentially life-saving product from millions of American consumers while paving the way for its own watch that copies Apple,” an Apple spokesperson said. “Although today's decision has no direct impact on sales Apple WatchWe believe it should be changed and will continue our efforts to appeal. “
Apple's patent “problem” with the Watch
In 2013, Apple tried to partner with Masimo. However, Masimo's CEO claimed that Apple had ulterior motives because it wanted to poach its employees. Later that year, Apple hired several employees from Masimo, including the chief medical officer, by offering them higher salaries. These employees had access to confidential information and trade secrets belonging to Massimo.
Masimo, which bills itself as the “inventor of modern pulse oximeters,” supplies its technology to many hospital equipment.
In 2020, Massimo filed a lawsuit against Apple for the theft of trade secrets and requested a ban on the sale of Apple Watches in the United States. A year later, the company accused Apple of patent infringement. The company claimed that Apple infringed 10 of their pulse oximeter patents when it launched the Watch Series 6.
In January this year, the US International Trade Commission (ITC) found that Apple infringed only one of Masimo's patents related to light-based pulse oximetry, but did not infringe the other nine patents. Now, the ITC has upheld a court order that may ban imports of Apple Watches Series 6 and newer models. However, the order does not specify exactly which models of Apple Watches will be affected by the ban.
Apple faces a second ban on imports of its Apple Watch over a separate patent dispute with medical technology company AliveCor. The ban was issued by the International Trade Commission (ITC) in February, but it is on hold pending related proceedings to determine the validity of AliveCor's patents.
The commission upheld a judge's ruling from January that found Apple infringed on Massimo's patent rights related to light-based technology used to measure oxygen levels in the blood. However, the decision will not have an immediate effect, as it must be reviewed by the President and is possible. addresses.
Masimo CEO Joe Qian said the decision “sends a strong message that even the world's largest company is not above the law”.
The Biden administration has 60 days to decide whether to veto the import ban based on policy concerns before it takes effect, although presidents have rarely vetoed bans in the past.
Apple also has the option to appeal the ban in the US Court of Appeals for the Federal Circuit after the review period ends.
“Masimo wrongly tried to use the ITC to keep a potentially life-saving product from millions of American consumers while paving the way for its own watch that copies Apple,” an Apple spokesperson said. “Although today's decision has no direct impact on sales Apple WatchWe believe it should be changed and will continue our efforts to appeal. “
Apple's patent “problem” with the Watch
In 2013, Apple tried to partner with Masimo. However, Masimo's CEO claimed that Apple had ulterior motives because it wanted to poach its employees. Later that year, Apple hired several employees from Masimo, including the chief medical officer, by offering them higher salaries. These employees had access to confidential information and trade secrets belonging to Massimo.
Masimo, which bills itself as the “inventor of modern pulse oximeters,” supplies its technology to many hospital equipment.
In 2020, Massimo filed a lawsuit against Apple for the theft of trade secrets and requested a ban on the sale of Apple Watches in the United States. A year later, the company accused Apple of patent infringement. The company claimed that Apple infringed 10 of their pulse oximeter patents when it launched the Watch Series 6.
In January this year, the US International Trade Commission (ITC) found that Apple infringed only one of Masimo's patents related to light-based pulse oximetry, but did not infringe the other nine patents. Now, the ITC has upheld a court order that may ban imports of Apple Watches Series 6 and newer models. However, the order does not specify exactly which models of Apple Watches will be affected by the ban.
Apple faces a second ban on imports of its Apple Watch over a separate patent dispute with medical technology company AliveCor. The ban was issued by the International Trade Commission (ITC) in February, but it is on hold pending related proceedings to determine the validity of AliveCor's patents.
